Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Capecitabine/Pembrolizumab/Ramucirumab

Delayed oesophageal anastomotic leak and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Roth RH, et al. Delayed esophageal anastomotic complication and ramucirumab therapy: A case report. Thoracic Cancer 14 : 2976-2980, Oct 2023. Available from: URL: https://dx.doi.org/10.1111/1759-7714.15084 Roth RH, et al. Delayed esophageal anastomotic complication and ramucirumab therapy: A case report. Thoracic Cancer 14 : 2976-2980, Oct 2023. Available from: URL: https://dx.doi.org/10.1111/1759-7714.15084
Metadaten
Titel
Capecitabine/Pembrolizumab/Ramucirumab
Delayed oesophageal anastomotic leak and lack of efficacy
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50906-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Dupilumab

Case report

Cotrimoxazole

Case report

Vasopressin

Case report

Adalimumab

Case report

Lithium